Reference health

Maintaining manganese in tumor to activate cGAS-STING pathway evokes a robust abscopal anti-tumor effect

https://doi.org/10.1016/j.jconrel.2021.01.036
CiteStamped reference-health badge
43/43 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 43 checked references that resolve
resolves10.1158/2159-8290.CD-17-0226
DNA Damage and Repair Biomarkers of Immunotherapy Response
resolves10.1259/0007-1285-26-305-234
Whole Body Irradiation—Radiobiology or Medicine?
resolves10.1016/j.immuni.2014.10.019
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
resolves10.1016/j.immuni.2014.10.017
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
resolves10.1093/jnci/djw199
Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
resolves10.1016/j.celrep.2018.11.054
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer
resolves10.1158/2159-8290.CD-18-1218
PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
resolves10.1158/2159-8290.CD-18-1020
Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer
resolves10.1158/0008-5472.CAN-18-1003
PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
resolves10.1172/JCI123319
PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
resolves10.1126/science.1232458
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
resolves10.1038/ni921
IKKε and TBK1 are essential components of the IRF3 signaling pathway
resolves10.1038/ni.3558
Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
resolves10.1038/nri3845
Type I interferons in anticancer immunity
resolves10.1016/j.immuni.2018.09.016
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
resolves10.1038/nrc.2016.14
Antitumour actions of interferons: implications for cancer therapy
resolves10.1038/s41573-018-0011-2
Interferons α and β in cancer: therapeutic opportunities from new insights
resolves10.1016/j.immuni.2017.07.016
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling
resolves10.1038/s41586-018-0705-y
Design of amidobenzimidazole STING receptor agonists with systemic activity
resolves10.1038/s41422-020-0346-1
Old dogs, new trick: classic cancer therapies activate cGAS
resolves10.1126/science.abb4255
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic
resolves10.1126/science.aba6098
An orally available non-nucleotide STING agonist with antitumor activity
resolves10.1084/jem.20180139
The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
resolves10.1016/j.ccell.2018.03.027
Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells
resolves10.1038/ncomms15618
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
resolves10.1038/s41577-018-0117-0
DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer
resolves10.1038/s41590-020-0751-0
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
resolves10.1016/j.immuni.2018.03.017
Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses
resolves10.1038/nature23470
Mitotic progression following DNA damage enables pattern recognition within micronuclei
resolves10.1016/S0966-7822(98)00035-5
Physico-chemical properties and rheology of alginate gel beads formed with various divalent cations
resolves10.1002/adfm.201504215
Smart Ferrofluid with Quick Gel Transformation in Tumors for MRI‐Guided Local Magnetic Thermochemotherapy
resolves10.1038/nbt.2450
Differential analysis of gene regulation at transcript resolution with RNA-seq
resolves10.1186/s12859-018-2486-6
iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
resolves10.1021/acsnano.8b03590
Tumor Oxygenation and Hypoxia Inducible Factor-1 Functional Inhibition <i>via</i> a Reactive Oxygen Species Responsive Nanoplatform for Enhancing Radiation Therapy and Abscopal Effects
resolves10.1016/j.cell.2014.11.037
Apoptotic Caspases Prevent the Induction of Type I Interferons by Mitochondrial DNA
resolves10.1016/j.cell.2014.11.036
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
resolves10.1042/ETLS20170063
TREX1 is a checkpoint for innate immune sensing of DNA damage that fosters cancer immune resistance
resolves10.1016/j.cell.2007.10.017
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
resolves10.1038/nature14292
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
resolves10.1038/s41422-020-00395-4
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy
resolves10.1046/j.1365-2036.2000.00759.x
Review article: alginate‐raft formulations in the treatment of heartburn and acid reflux
resolves10.1016/j.celrep.2015.04.031
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
resolves10.1038/s41565-018-0342-5
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
The 4 references without a DOI — listed, not checked
no DOI — not checkedRadiotherapy combination opportunities leveraging immunity for the next oncology practice
no DOI — not checkedMaterial properties of alginates
no DOI — not checkedTo determine the complexing constants of several alginates
no DOI — not checked10.1016/j.jconrel.2021.01.036_bb0190
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.jconrel.2021.01.036"><img src="https://citestamp.com/citestamped/10.1016/j.jconrel.2021.01.036/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.jconrel.2021.01.036/badge.svg)](https://citestamp.com/citestamped/10.1016/j.jconrel.2021.01.036)